Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

This publication has 44 references indexed in Scilit:

• Relationship between circulating FGF23 and total body atherosclerosis in the community
  Nephrology Dialysis Transplantation, 2009
• Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
  Atherosclerosis, 2009
• Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
  New England Journal of Medicine, 2008
• The parathyroid is a target organ for FGF23 in rats
  Journal of Clinical Investigation, 2007
• Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m²from the cystatin C values in mg/L
  Scandinavian Journal of Clinical and Laboratory Investigation, 2007
• Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
  New England Journal of Medicine, 2004
• Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left ventricular hypertrophy progression
  Kidney International, 2004
• Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX
  Journal of Biological Chemistry, 2003
• Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study
  New England Journal of Medicine, 1990
• Impact of left ventricular hypertrophy on survival in end-stage renal disease
  Kidney International, 1989